Previous 10 | Next 10 |
RANCHO CUCAMONGA, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended September 30, 2020. Third Quarter Highlights Net revenues o...
RANCHO CUCAMONGA, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its third quarter of 2020 ended September 30, 2020, before the market opens on Friday, November 6 th , 2020, and will hold a con...
The FDA has approved Amphastar Pharmaceuticals' (AMPH) Abbreviated New Drug Application ((ANDAs)) for Atropine Sulfate injection 0.1mg/mL in the 10 mL Luer-Jet prefilled syringe system, a preoperative medication for the reduction of salivary and bronchial se...
RANCHO CUCAMONGA, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) approved the Company’s Abbreviated New Drug Application (“ANDA”) for Atropine Sulfate in...
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with this Read more ...
RANCHO CUCAMONGA, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan Dischner, Vice President of Corporate Communications and Human Resources, and Tony Marrs, Sr. Vice President Regulatory Affairs and Clinical...
Aquestive Therapeutics (NASDAQ: AQST ) initiates a Phase 1 clinical trial in 28 healthy volunteers evaluating the safety and pharmacokinetics (PK) of AQST-108, an oral sublingual formulation of epinephrine, for the potential treatment of allergic reactions, including anaphylaxis (ac...
Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2020 Earnings Conference Call August 6, 2020 5:00 PM ET Company Participants Dan Dischner – Vice President of Human Resources and Corporate Communications Bill Peters – Chief Financial Officer Tony Marrs – Senior Vice...
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with their 2020 Q2 earnings Read more ...
Image source: The Motley Fool. Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Q2 2020 Earnings Call Aug 6, 2020 , 5:00 p.m. ET Operator Continue reading
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Complete Solaria Inc Com (CSLR) rose 58.5% to $1.775 on volume of 71,457,263 shares Senti Biosciences Inc. (SNTI) rose 55.1% to $0.428 on volume of 64,207,396 shares Golden Heaven Group Holdings Ltd. (GDHG) rose 13.3% to $0.1711 on vo...
2024-06-19 18:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...